GVR Report cover Bioanalytical Testing Services Market Size, Share & Trends Report

Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small, Large), By Test (ADME, PD, PK, Others), By Workflow, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-946-3
  • Number of Report Pages: 180
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Bioanalytical Testing Services Market Trends

The global bioanalytical testing services market was valued at USD 4.33 billion in 2023 and is anticipated to grow at a CAGR of 9.0% over the forecast period. Increasing drug development and approval processes, increasing complexity of therapeutics, and rise in outsourcing of testing services are key factors anticipated to drive the market in the coming years. The development of complex therapeutic modalities, such as gene therapies andbiologics, has created a need for specialized bioanalytical testing services.

U.S. Bioanalytical Testing Services Market size and growth rate, 2024 - 2030

Bioanalytical Testing Services Market Trends

  • Increased Outsourcing: Pharmaceutical and biotechnology companies continue to outsource bioanalytical testing services to specialized firms to enhance efficiency and focus on core competencies.

  • Technological Advancements: The industry is likely to witness ongoing technological advancements, such as the integration of high-throughput screening methods, automation, and advanced analytical techniques, to improve accuracy and speed of bioanalytical testing.

  • Focus on Biopharmaceuticals: With the increasing development and approval of biopharmaceuticals, there is a growing need for specialized bioanalytical testing services tailored to the unique characteristics of biologics.

Moreover, an increasing frequency of outsourcing R&D activities by a major pharmaceutical companies to focus on their core competencies is the vital impact rendering driver for this market. Furthermore, economic efficiency offered by outsourcing rather than conducting an in-house study is expected to boost the demand over the forecast period. Innovation and new product development are expected to further boost the demand for these services. Competitive pressure and pricing concerns are driving companies to outsource such services. This, in turn, is expected to augment the overall market growth.

Growing focus on a development of advanced bioanalytical technologies for enhanced testing is expected to contribute to market growth. The development of biosimilars, combination products, and other innovative medicines has increased the demand for specific testing procedures. The coronavirus pandemic has resulted in disruptions in the supply chain of the overall pharmaceutical industry. However, the market for bioanalytical testing services responded well to the outbreak. The pandemic resulted in the expansion of R&D and manufacturing operations of key stakeholders leading to a surge in demand for these services.

In addition, increasing frequency of outsourcing R&D activities by the major pharmaceutical companies to focus on their core competencies is a vital impact rendering driver for this market. Furthermore, the economic efficiency offered by outsourcing rather than conducting an in-house study is expected to boost demand over the forecast period. Innovation and new product development are expected to further boost the demand for these services. Competitive pressure and pricing concerns are driving companies to outsource such services. This, in turn, is expected to augment the overall bioanalytical testing services market growth.

Growing consumer concern about self-care is increasing consumption of pharmaceutical products. However, some areas have lower accessibility to bioanalytical testing services. Therefore, to overcome this problem, end users are promoting in-house tests and expanding testing capabilities in various locations to help meet a growing demand.For instance, in February 2023, SGS expanded its business with an opening of testing lab in the district of Pudong, Shanghai.

Market Concentration & Characteristics

The global bioanalytical testing services market is characterized by a high degree of innovation. Advances in technologies such as chromatography, mass spectrometry, and immunoassays have been heavily incorporated into clinical trial procedures. Moreover, an increasing complexity of data generated during bioanalytical testing demands innovations in data integration and analysis.

Bioanalytical Testing Services Market Concentration & Characteristics

Several market players, such as SGS, U.S. Holdings, Inc., Eurofins Scientific, and IQVIA Inc., are involved in merger and acquisition activities. Through M&A activity, these entities can expand their geographic reach and strengthen their market position.

The impact of Regulations is expected to be significant due to highly stringent regulatory compliance requirements. Rigorous regulatory standards are established to ensure that drugs and therapies undergoing testing are safe and effective.

The key companies in a market are implementing diverse strategic initiatives to expand their operations and establish a stronger foothold in new geographical areas. This expansion enables key companies to enter markets characterized by specific needs or opportunities.

Molecule Insights

On the basis of molecules, the global market has been segmented into small and large molecules. The small molecule segment accounted for a largest revenue share of 55.6% in 2023. Growth in the segment can be attributed to medical breakthroughs related to small molecules and unmet medical needs. In addition, small molecules, such as chemical probes, have been playing a vital role in biomedical research, aiding the understanding of disease biology. The key bioanalytical tests for small molecules include PK, pharmacodynamics, bioavailability, and other biopharmaceutical tests.Moreover, generic and branded drug compounds are mostly small molecules. In addition, generic manufacturers have to conduct and submit bioanalytical testing results due to increasing patent expiration. This, in, turn, drives an adoption of bioanalytical testing for small molecules.

Large molecule bioanalytical testing services market is expected to grow the fastest at a CAGR of 9.61% from 2024 to 2030. With the increasing complexity of large molecules, including monoclonal antibodies and gene therapies, there is a heightened demand for specialized bioanalytical testing services to ensure the safety, efficacy, and regulatory compliance of these innovative therapeutic modalities. The globalization of clinical trials, continuous technological innovations, and substantial investments in healthcare research further contribute to the robust growth trajectory of this market over the forecast period.

Workflow Insights

In terms of workflow, the sample analysis segment dominated the market and accounted for the largest revenue share of more than 45.6% in 2023. Sample analysis plays an important role in the drug development and marketing stages. This workflow helps in the quantitation of impurities, assessing stability of drug molecules, and identification of impurities present in the sample. Hence, growing rate of drug development is one of the crucial factors boosting the demand for sample analysis, thus augmenting the segment’s share.

Sample Preparation segment is expected to register CAGR of 9.40% over the forecast period. Sample preparation is an analytical step that contains extraction procedures to help extract the component required from the matrix. The process varies based on degree of selectivity, convenience, speed, and configurations of extraction phase. Nontraditional extraction technologies are being introduced to address growing demand for automation, reduction of sot use, and miniaturization. These technologies result in on-site in situ and in vivo implementation.

Test Insights

On the basis of tests, the global market has been segmented into Absorption Distribution Metabolism Excretion (ADME), Pharmacokinetics (PK), Pharmacodynamics (PD), bioavailability, bioequivalence, and other test types. The bioavailability segment accounted for a highest share of more than 18.7% of the global revenue in 2023 owing to a high demand for such services in generic drug development. Bioavailability studies offer major benefits in studying new drugs after administration and help in establishing an equivalence between early & late clinical trial formulations. This technique helps establish an equivalence between formulations used in clinical trials and stability studies.

Global Bioanalytical Testing Services Market share and size, 2023

Bioequivalance segment is expected to register CAGR of 9.42% over a forecast period. Growing adoption of bioequivalence and rising number of clinical trials support the development of cost-efficient generics or biosimilars. For instance, in October 2022, the completion of PK comparability clinical trial for Ustekinumab Biosimilar (BFI-751) was announced BioFactura Inc. It was conducted in two sites in New Zealand and Australia.

Regional Insights

North America dominated the global market in 2023 and accounted for a largest revenue share of more than 46.3%. This is attributed to growing investment in R&D of new drugs by pharmaceutical and biotechnology industries. As this activity increases, the demand for bioanalytical testing services also grows. Growth of pharmaceutical industries in the U.S. and Canada is a contributing factor. In addition, a substantial presence of key market players and ongoing clinical trials are anticipated to drive the regional bioanalytical testing services market growth.

The U.S. accounts for highest share in the global bioanalytical testing services market, as many pharmaceutical and biotechnology companies are in this region. Increased R&D investments and a rising need for biopharmaceutical products are key drivers for the market's expansion. The demand for specific tests, including electrophoresis, electrochemical & titrimetric assays, and immunoassays, has seen a notable upswing due to a development of combination molecules, biosimilars, and other innovative medicines.

Bioanalytical Testing Services Market Trends by Region, 2024 - 2030

In Asia Pacific, the market for bioanalytical testing services is anticipated to witness a fastest growth rate of 9.69% from 2024 to 2030. This is due to increasing pharmaceutical & biotechnology activities, rising healthcare expenditure, increasing investments by companies from developed economies in enhancing regional healthcare, and amendments made by regulatory bodies for changing clinical trial evaluation standards to align with a global standards. Furthermore, key companies are establishing new facilities and forming alliances to increase a reach of their offerings to various locations in the region.

China has become an attractive destination for outsourcing clinical trials due to its large population, diverse patient demographics, and cost-effectiveness. As a result, both domestic and international pharmaceutical companies outsource their clinical trials to CROs in China, driving a demand for bioanalytical testing services.

Key Companies & Market Share Insights

Several factors influence the company share in the bioanalytical testing services market. These include service portfolio and expertise, technological capabilities, global presence, strategic initiatives among others. Companies such as Labcorp, Charles River Laboratories, ICON plc, SGS SA, Thermo Fischer, and IQVIA hold a notable share of the market. This is owing to their comprehensive service portfolio covering a wide range of bioanalytical testing services and demonstrating expertise in handling diverse types of molecules (small molecules, large molecules). Moreover, these companies are continuously investing in cutting-edge technologies and state-of-the-art analytical instrumentation for bioanalytical testing to offer more accurate and efficient services. This technological advantage helps attract clients and contribute to a larger market share. The multinational presence of these companies coupled with implementation of strategic initiatives such as partnerships, mergers & acquisitions contribute to the company’s market presence.

Key Bioanalytical Testing Services Companies:

  • Thermo Fisher Scientific Inc (PPD, Inc.)
  • ICON Plc
  • Charles River Laboratories International
  • Covance, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA
  • Labcorp (Toxikon)
  • Intertek Group Plc
  • Pace Analytical Services LLC

Recent Developments

  • In September 2023, Cerba HealthCare completed an acquisition of CIRION BioPharma Research, a Canadian contract research laboratory, to enhance bioanalytical capabilities and streamline a deployment of complex clinical trials.

  • In November 2023, Resolian successfully acquired Denali Medpharma, a prominent bioanalytical CRO based in China. With this acquisition, Resolian has expanded its bioanalysis laboratory operations to include the U.S., UK, Australia, and China facilities.

  • In April 2023, Pace Analytical Services announced the acquisition of Alpha Analytical and expanded its laboratory services in the Northeast U.S. with over 39 Locations.

Bioanalytical Testing Services Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 4.73 billion

Revenue forecast in 2030

USD 7.93 billion

Growth Rate

CAGR of 9.0% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Molecule, test, workflow, application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Netherlands; Switzerland; Sweden; Denmark; Norway; India; China; Japan; Australia; South Korea; Indonesia; Malaysia; Singapore; Thailand; Taiwan; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Israel; Kuwait

Key companies profiled

Thermo Fisher Scientific Inc (PPD, Inc.), ICON Plc., Charles River Laboratories International, Covance, Inc., IQVIA, Syneos Health, SGS SA, Labcorp (Toxikon), Intertek Group Plc., Pace Analytical Services LLC

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Bioanalytical Testing Services Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the bioanalytical testing services market based on molecule, test, workflow, application, end-use, and region:

Global Bioanalytical Testing Services Market Report Segmentation

  • Molecule Outlook (Revenue, USD Billion, 2018 - 2030)

    • Small Molecule

    • Large Molecule

      • LC-MS Studies

      • Immunoassays

      • PK

      • ADA

      • Others

    • Others

  • Test Outlook (Revenue, USD Billion, 2018 - 2030)

    • ADME

      • In-Vivo

      • In-Vitro

    • PK

    • PD

    • Bioavailability

    • Bioequivalence

    • Others

  • Workflow Outlook (Revenue, USD Billion, 2018 - 2030)

    • Sample Preparation

      • Protein Precipitation

      • Liquid-Liquid Extraction

      • Solid Phase Extraction

    • Sample Analysis

      • Hyphenated technique

      • Chromatographic technique

      • Electrophoresis

      • Ligand Binding Assay

      • Mass Spectrometry

      • Nuclear Magnetic Resonance

    • Other Workflow Processes

  • Application Outlook (Revenue, USD Billion, 2018 - 2030)

    • Oncology

    • Neurology

    • Infectious Diseases

    • Gastroenterology

    • Cardiology

    • Other Applications

  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)

    • Pharma & BioPharma Companies

    • CDMO

    • CRO

  • Regional Outlook (Revenue, USD Billion, 2018- 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

      • Netherlands

      • Switzerland

    • Asia Pacific

      • India

      • China

      • Japan

      • South Korea

      • Australia

      • Thailand

      • Indonesia

      • Malaysia

      • Singapore

      • Taiwan

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

      • Israel

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Information Procurement
                      1.2. Information or Data Analysis
                      1.3. Market Scope & Segment Definition
                      1.4. Market Model
Chapter 2. Executive Summary
                      2.1. Market Snapshot
                      2.2. Segment Snapshot
                      2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                      3.1. Market Segmentation and Scope
                      3.2. Market Lineage Outlook
                          3.2.1. Parent Market Outlook
                          3.2.2. Related/Ancillary Market Outlook
                      3.3. Market Trends and Outlook
                      3.4. Market Dynamics
                      3.5. Market Driver Analysis
                      3.6. Market Restraint Analysis
                      3.7. Business Environment Analysis
                          3.7.1. SWOT Analysis
                          3.7.2. Porter’s Five Forces Analysis
                      3.8. COVID-19 Impact Analysis
Chapter 4. Molecule Business Analysis
                      4.1. Bioanalytical Testing Services Market, By Molecule: Segment Dashboard
                      4.2. Bioanalytical Testing Services Market, By Molecule: Movement Analysis
                      4.3. Bioanalytical Testing Services Market Estimates & Forecasts, By Molecule, 2018 - 2030
                          4.3.1. Small Molecule
                              4.3.1.1. Small Molecule Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                              4.3.1.2. Large Molecule
                                  4.3.1.2.1. Large Molecule Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                                  4.3.1.2.2. LC-MS Studies
                                      4.3.1.2.2.1. LC-MS Studies Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                                  4.3.1.2.3. Immunoassays
                                      4.3.1.2.3.1. Immunoassays Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                                      4.3.1.2.3.2. PK
                                          4.3.1.2.3.2.1. PK Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                                      4.3.1.2.3.3. ADA
                                          4.3.1.2.3.3.1. ADA Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                                      4.3.1.2.3.4. Others
                                          4.3.1.2.3.4.1. Others Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                                  4.3.1.2.4. Others
                                      4.3.1.2.4.1. Others Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
Chapter 5. Test Business Analysis
                      5.1. Bioanalytical Testing Services Market, By Test: Segment Dashboard
                      5.2. Bioanalytical Testing Services Market, By Test: Movement Analysis
                      5.3. Bioanalytical Testing Services Market Estimates & Forecasts, By Test, 2018 - 2030
                          5.3.1. ADME
                              5.3.1.1. ADME Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                              5.3.1.2. In-Vivo
                                  5.3.1.2.1. In-Vivo Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                              5.3.1.3. In-Vitro
                                  5.3.1.3.1. In-Vitro Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          5.3.2. PK
                              5.3.2.1. PK Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          5.3.3. PD
                              5.3.3.1. PD Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          5.3.4. Bioavailability
                              5.3.4.1. Bioavailability Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          5.3.5. Bioequivalence
                              5.3.5.1. Bioequivalence Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          5.3.6. Others
                              5.3.6.1. Others Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
Chapter 6. Application Business Analysis
                      6.1. Bioanalytical Testing Services Market, By Application: Segment Dashboard
                      6.2. Bioanalytical Testing Services Market, By Application: Movement Analysis
                      6.3. Bioanalytical Testing Services Market Estimates & Forecasts, By Application, 2018 - 2030
                          6.3.1. Oncology
                              6.3.1.1. Oncology Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          6.3.2. Neurology
                              6.3.2.1. Neurology Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          6.3.3. Infectious Diseases
                              6.3.3.1. Infectious Diseases Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          6.3.4. Gastroenterology
                              6.3.4.1. Gastroenterology Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          6.3.5. Cardiology
                              6.3.5.1. Cardiology Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          6.3.6. Other Applications
                              6.3.6.1. Other Applications Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
Chapter 7. End Use Business Analysis
                      7.1. Bioanalytical Testing Services Market, By End Use: Segment Dashboard
                      7.2. Bioanalytical Testing Services Market, By End Use: Movement Analysis
                      7.3. Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030
                          7.3.1. Pharma & BioPharma Companies
                              7.3.1.1. Pharma & BioPharma Companies Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          7.3.2. CDMO
                              7.3.2.1. CDMO Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
                          7.3.3. CRO
                              7.3.3.1. CRO Bioanalytical Testing Services Market, 2018 to 2030 (USD Billion)
Chapter 8. Regional Business Analysis
                      8.1. Regional Market Share Analysis, 2023 & 2030
                      8.2. Regional Market Dashboard
                      8.3. Global Regional Market Snapshot
                      8.4. North America
                          8.4.1. North America Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.4.2. U.S.
                              8.4.2.1. Key Country Dynamics
                              8.4.2.2. Regulatory Framework
                              8.4.2.3. Competitive Scenario
                              8.4.2.4. U.S. Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.4.3. Canada
                              8.4.3.1. Key Country Dynamics
                              8.4.3.2. Regulatory Framework
                              8.4.3.3. Competitive Scenario
                              8.4.3.4. Canada Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                      8.5. Europe
                          8.5.1. Europe Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.2. UK
                              8.5.2.1. Key Country Dynamics
                              8.5.2.2. Competitive Scenario
                              8.5.2.3. UK Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.3. Germany
                              8.5.3.1. Key Country Dynamics
                              8.5.3.2. Competitive Scenario
                              8.5.3.3. Germany Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.4. France
                              8.5.4.1. Key Country Dynamics
                              8.5.4.2. Competitive Scenario
                              8.5.4.3. France Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.5. Italy
                              8.5.5.1. Key Country Dynamics
                              8.5.5.2. Competitive Scenario
                              8.5.5.3. Italy Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.6. Spain
                              8.5.6.1. Key Country Dynamics
                              8.5.6.2. Competitive Scenario
                              8.5.6.3. Spain Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.7. Sweden
                              8.5.7.1. Key Country Dynamics
                              8.5.7.2. Competitive Scenario
                              8.5.7.3. Sweden Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.8. Norway
                              8.5.8.1. Key Country Dynamics
                              8.5.8.2. Competitive Scenario
                              8.5.8.3. Norway Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.9. Denmark
                              8.5.9.1. Key Country Dynamics
                              8.5.9.2. Competitive Scenario
                              8.5.9.3. Denmark Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.10. Switzerland
                              8.5.10.1. Key Country Dynamics
                              8.5.10.2. Competitive Scenario
                              8.5.10.3. Switzerland Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.5.11. Netherlands
                              8.5.11.1. Key Country Dynamics
                              8.5.11.2. Competitive Scenario
                              8.5.11.3. Netherlands Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                      8.6. Asia Pacific
                          8.6.1. Asia Pacific Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.2. Japan
                              8.6.2.1. Key Country Dynamics
                              8.6.2.2. Competitive Scenario
                              8.6.2.3. Japan Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.3. China
                              8.6.3.1. Key Country Dynamics
                              8.6.3.2. Competitive Scenario
                              8.6.3.3. China Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.4. India
                              8.6.4.1. Key Country Dynamics
                              8.6.4.2. Competitive Scenario
                              8.6.4.3. India Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.5. Australia
                              8.6.5.1. Key Country Dynamics
                              8.6.5.2. Competitive Scenario
                              8.6.5.3. Australia Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.6. South Korea
                              8.6.6.1. Key Country Dynamics
                              8.6.6.2. Competitive Scenario
                              8.6.6.3. South Korea Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.7. Thailand
                              8.6.7.1. Key Country Dynamics
                              8.6.7.2. Competitive Scenario
                              8.6.7.3. Thailand Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.8. Taiwan
                              8.6.8.1. Key Country Dynamics
                              8.6.8.2. Competitive Scenario
                              8.6.8.3. Taiwan Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.9. Indonesia
                              8.6.9.1. Key Country Dynamics
                              8.6.9.2. Competitive Scenario
                              8.6.9.3. Indonesia Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.10. Malaysia
                              8.6.10.1. Key Country Dynamics
                              8.6.10.2. Competitive Scenario
                              8.6.10.3. Malaysia Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.6.11. Singapore
                              8.6.11.1. Key Country Dynamics
                              8.6.11.2. Competitive Scenario
                              8.6.11.3. Singapore Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                      8.7. Latin America
                          8.7.1. Latin America Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.7.2. Brazil
                              8.7.2.1. Key Country Dynamics
                              8.7.2.2. Competitive Scenario
                              8.7.2.3. Brazil Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.7.3. Mexico
                              8.7.3.1. Key Country Dynamics
                              8.7.3.2. Competitive Scenario
                              8.7.3.3. Mexico Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.7.4. Argentina
                              8.7.4.1. Key Country Dynamics
                              8.7.4.2. Competitive Scenario
                              8.7.4.3. Argentina Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.7.5. Colombia
                              8.7.5.1. Key Country Dynamics
                              8.7.5.2. Competitive Scenario
                              8.7.5.3. Colombia Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                      8.8. MEA
                          8.8.1. MEA Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.8.2. South Africa
                              8.8.2.1. Key Country Dynamics
                              8.8.2.2. Competitive Scenario
                              8.8.2.3. South Africa Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.8.3. Saudi Arabia
                              8.8.3.1. Key Country Dynamics
                              8.8.3.2. Competitive Scenario
                              8.8.3.3. Saudi Arabia Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.8.4. UAE
                              8.8.4.1. Key Country Dynamics
                              8.8.4.2. Competitive Scenario
                              8.8.4.3. UAE Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.8.5. Kuwait
                              8.8.5.1. Key Country Dynamics
                              8.8.5.2. Competitive Scenario
                              8.8.5.3. Kuwait Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
                          8.8.6. Israel
                              8.8.6.1. Key Country Dynamics
                              8.8.6.2. Competitive Scenario
                              8.8.6.3. Israel Bioanalytical Testing Services Market, 2018 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
                      9.1. Company Categorization
                      9.2. Strategy Mapping
                          9.2.1. Merger& Acquisition
                          9.2.2. Collaborations
                          9.2.3. New Product Launch
                      9.3. Participant’s overview
                          9.3.1. Thermo Fisher Scientific Inc (PPD, Inc.)
                              9.3.1.1. Overview
                              9.3.1.2. Financial Performance
                              9.3.1.3. Product Benchmarking
                              9.3.1.4. Strategic Initiatives
                          9.3.2. ICON Plc
                              9.3.2.1. Overview
                              9.3.2.2. Financial Performance
                              9.3.2.3. Product Benchmarking
                              9.3.2.4. Strategic Initiatives
                          9.3.3. Charles River Laboratories International
                              9.3.3.1. Overview
                              9.3.3.2. Financial Performance
                              9.3.3.3. Product Benchmarking
                              9.3.3.4. Strategic Initiatives
                          9.3.4. Covance, Inc.
                              9.3.4.1. Overview
                              9.3.4.2. Financial Performance
                              9.3.4.3. Product Benchmarking
                              9.3.4.4. Strategic Initiatives
                          9.3.5. IQVIA
                              9.3.5.1. Overview
                              9.3.5.2. Financial Performance
                              9.3.5.3. Product Benchmarking
                              9.3.5.4. Strategic Initiatives
                          9.3.6. Syneos Health
                              9.3.6.1. Overview
                              9.3.6.2. Financial Performance
                              9.3.6.3. Product Benchmarking
                              9.3.6.4. Strategic Initiatives
                          9.3.7. SGS SA
                              9.3.7.1. Overview
                              9.3.7.2. Financial Performance
                              9.3.7.3. Product Benchmarking
                              9.3.7.4. Strategic Initiatives
                          9.3.8. Labcorp (Toxikon)
                              9.3.8.1. Overview
                              9.3.8.2. Financial Performance
                              9.3.8.3. Product Benchmarking
                              9.3.8.4. Strategic Initiatives
                          9.3.9. Intertek Group Plc
                              9.3.9.1. Overview
                              9.3.9.2. Financial Performance
                              9.3.9.3. Product Benchmarking
                              9.3.9.4. Strategic Initiatives
                          9.3.10. Pace Analytical Services LLC
                              9.3.10.1. Overview
                              9.3.10.2. Financial Performance
                              9.3.10.3. Product Benchmarking
                              9.3.10.4. Strategic Initiatives


List of Tables

Table 1 List of secondary sources
Table 2 Global Bioanalytical Testing Services market, by region, 2018 - 2030 (USD Million)
Table 3 Global Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 4 Global Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 5 Global Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 6 Global Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 7 Global Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 8 Global Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 9 Global Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 10 Global ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 11 Global Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 12 Global Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 13 North America Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 14 North America Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 15 North America Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 16 North America Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 17 North America Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 18 North America Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 19 North America Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 20 North America Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 21 North America ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 22 North America Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 23 North America Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 24 U.S. Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 25 U.S. Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 26 U.S. Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 27 U.S. Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 28 U.S. Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 29 U.S. Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 30 U.S. Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 31 U.S. ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 32 U.S. Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 33 U.S. Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 34 Canada Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 35 Canada Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 36 Canada Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 37 Canada Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 38 Canada Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 39 Canada Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 40 Canada Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 41 Canada ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 42 Canada Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 43 Canada Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 44 Europe Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 45 Europe Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 46 Europe Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 47 Europe Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 48 Europe Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 49 Europe Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 50 Europe Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 51 Europe Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 52 Europe ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 53 Europe Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 54 Europe Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 55 Germany Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 56 Germany Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 57 Germany Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 58 Germany Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 59 Germany Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 60 Germany Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 61 Germany Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 62 Germany ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 63 Germany Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 64 Germany Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 65 UK Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 66 UK Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 67 UK Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 68 UK Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 69 UK Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 70 UK Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 71 UK Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 72 UK ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 73 UK Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 74 UK Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 75 France Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 76 France Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 77 France Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 78 France Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 79 France Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 80 France Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 81 France Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 82 France ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 83 France Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 84 France Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 85 Italy Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 86 Italy Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 87 Italy Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 88 Italy Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 89 Italy Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 90 Italy Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 91 Italy Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 92 Italy ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 93 Italy Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 94 Italy Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 95 Spain Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 96 Spain Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 97 Spain Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 98 Spain Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 99 Spain Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 100 Spain Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 101 Spain Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 102 Spain ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 103 Spain Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 104 Spain Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 105 Denmark Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 106 Denmark Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 107 Denmark Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 108 Denmark Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 109 Denmark Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 110 Denmark Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 111 Denmark Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 112 Denmark ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 113 Denmark Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 114 Denmark Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 115 Sweden Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 116 Sweden Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 117 Sweden Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 118 Sweden Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 119 Sweden Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 120 Sweden Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 121 Sweden Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 122 Sweden ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 123 Sweden Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 124 Sweden Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 125 Norway Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 126 Norway Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 127 Norway Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 128 Norway Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 129 Norway Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 130 Norway Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 131 Norway Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 132 Norway ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 133 Norway Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 134 Norway Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 135 Netherlands Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 136 Netherlands Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 137 Netherlands Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 138 Netherlands Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 139 Netherlands Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 140 Netherlands Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 141 Netherlands Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 142 Netherlands ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 143 Netherlands Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 144 Netherlands Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 145 Switzerland Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 146 Switzerland Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 147 Switzerland Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 148 Switzerland Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 149 Switzerland Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 150 Switzerland Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 151 Switzerland Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 152 Switzerland ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 153 Switzerland Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 154 Switzerland Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 155 Asia Pacific Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 156 Asia Pacific Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 157 Asia Pacific Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 158 Asia Pacific Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 159 Asia Pacific Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 160 Asia Pacific Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 161 Asia Pacific Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 162 Asia Pacific Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 163 Asia Pacific ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 164 Asia Pacific Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 165 Asia Pacific Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 166 China Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 167 China Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 168 China Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 169 China Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 170 China Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 171 China Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 172 China Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 173 China ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 174 China Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 175 China Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 176 Japan Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 177 Japan Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 178 Japan Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 179 Japan Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 180 Japan Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 181 Japan Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 182 Japan Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 183 Japan ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 184 Japan Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 185 Japan Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 186 India Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 187 India Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 188 India Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 189 India Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 190 India Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 191 India Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 192 India Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 193 India ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 194 India Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 195 India Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 196 South Korea Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 197 South Korea Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 198 South Korea Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 199 South Korea Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 200 South Korea Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 201 South Korea Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 202 South Korea Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 203 South Korea ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 204 South Korea Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 205 South Korea Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 206 Australia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 207 Australia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 208 Australia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 209 Australia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 210 Australia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 211 Australia Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 212 Australia Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 213 Australia ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 214 Australia Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 215 Australia Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 216 Thailand Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 217 Thailand Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 218 Thailand Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 219 Thailand Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 220 Thailand Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 221 Thailand Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 222 Thailand Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 223 Thailand ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 224 Thailand Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 225 Thailand Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 226 Indonesia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 227 Indonesia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 228 Indonesia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 229 Indonesia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 230 Indonesia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 231 Indonesia Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 232 Indonesia Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 233 Indonesia ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 234 Indonesia Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 235 Indonesia Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 236 Malaysia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 237 Malaysia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 238 Malaysia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 239 Malaysia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 240 Malaysia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 241 Malaysia Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 242 Malaysia Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 243 Malaysia ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 244 Malaysia Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 245 Malaysia Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 246 Singapore Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 247 Singapore Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 248 Singapore Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 249 Singapore Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 250 Singapore Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 251 Singapore Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 252 Singapore Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 253 Singapore ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 254 Singapore Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 255 Singapore Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 256 Taiwan Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 257 Taiwan Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 258 Taiwan Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 259 Taiwan Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 260 Taiwan Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 261 Taiwan Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 262 Taiwan Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 263 Taiwan ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 264 Taiwan Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 265 Taiwan Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 266 Latin America Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 267 Latin America Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 268 Latin America Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 269 Latin America Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 270 Latin America Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 271 Latin America Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 272 Latin America Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 273 Latin America Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 274 Latin America ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 275 Latin America Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 276 Latin America Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 277 Brazil Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 278 Brazil Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 279 Brazil Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 280 Brazil Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 281 Brazil Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 282 Brazil Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 283 Brazil Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 284 Brazil ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 285 Brazil Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 286 Brazil Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 287 Mexico Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 288 Mexico Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 289 Mexico Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 290 Mexico Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 291 Mexico Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 292 Mexico Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 293 Mexico Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 294 Mexico ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 295 Mexico Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 296 Mexico Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 297 Argentina Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 298 Argentina Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 299 Argentina Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 300 Argentina Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 301 Argentina Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 302 Argentina Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 303 Argentina Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 304 Argentina ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 305 Argentina Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 306 Argentina Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 307 Colombia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 308 Colombia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 309 Colombia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 310 Colombia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 311 Colombia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 312 Colombia Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 313 Colombia Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 314 Colombia ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 315 Colombia Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 316 Colombia Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 317 MEA Bioanalytical Testing Services market, by country, 2018 - 2030 (USD Million)
Table 318 MEA Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 319 MEA Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 320 MEA Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 321 MEA Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 322 MEA Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 323 MEA Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 324 MEA Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 325 MEA ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 326 MEA Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 327 MEA Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 328 South Africa Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 329 South Africa Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 330 South Africa Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 331 South Africa Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 332 South Africa Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 333 South Africa Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 334 South Africa Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 335 South Africa ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 336 South Africa Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 337 South Africa Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 338 Saudi Arabia Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 339 Saudi Arabia Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 340 Saudi Arabia Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 341 Saudi Arabia Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 342 Saudi Arabia Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 343 Saudi Arabia Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 344 Saudi Arabia Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 345 Saudi Arabia ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 346 Saudi Arabia Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 347 Saudi Arabia Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 348 UAE Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 349 UAE Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 350 UAE Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 351 UAE Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 352 UAE Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 353 UAE Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 354 UAE Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 355 UAE ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 356 UAE Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 357 UAE Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 358 Kuwait Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 359 Kuwait Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 360 Kuwait Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 361 Kuwait Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 362 Kuwait Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 363 Kuwait Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 364 Kuwait Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 365 Kuwait ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 366 Kuwait Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 367 Kuwait Sample Analysis Market, by Type, 2018 - 2030 (USD Million)
Table 368 Israel Bioanalytical Testing Services market, by Molecule, 2018 - 2030 (USD Million)
Table 369 Israel Bioanalytical Testing Services market, by Test, 2018 - 2030 (USD Million)
Table 370 Israel Bioanalytical Testing Services market, by Workflow, 2018 - 2030 (USD Million)
Table 371 Israel Bioanalytical Testing Services market, by End Use, 2018 - 2030 (USD Million)
Table 372 Israel Bioanalytical Testing Services market, by Application, 2018 - 2030 (USD Million)
Table 373 Israel Large Molecule Bioanalytical Testing, by Tests, 2018 - 2030 (USD Million)
Table 374 Israel Large Molecule Immunoassay Tests, by Type, 2018 - 2030 (USD Million)
Table 375 Israel ADME Tests Market, by Type, 2018 - 2030 (USD Million)
Table 376 Israel Sample Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 377 Israel Sample Analysis Market, by Type, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Bioanalytical Testing Services Market , Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 14 Regional Marketplace: Key Takeaways
Fig. 15 Global Bioanalytical Testing Services Market for Small Molecule, 2018 - 2030 (USD Billion)
Fig. 16 Global Bioanalytical Testing Services Market for Large Molecule, 2018 - 2030 (USD Billion)
Fig. 17 Global Bioanalytical Testing Services Market for LC-MS Studies, 2018 - 2030 (USD Billion)
Fig. 18 Global Bioanalytical Testing Services Market for Immunoassays, 2018 - 2030 (USD Billion)
Fig. 19 Global Bioanalytical Testing Services Market for Other Large Molecule Tests, 2018 - 2030 (USD Billion)
Fig. 20 Global Bioanalytical Testing Services Market for PK, 2018 - 2030 (USD Billion)
Fig. 21 Global Bioanalytical Testing Services Market for ADA, 2018 - 2030 (USD Billion)
Fig. 22 Global Bioanalytical Testing Services Market for Other , 2018 - 2030 (USD Billion)
Fig. 23 Global Bioanalytical Testing Services Market for ADME, 2018 - 2030 (USD Billion)
Fig. 24 Global Bioanalytical Testing Services Market for In-Vivo, 2018 - 2030 (USD Billion)
Fig. 25 Global Bioanalytical Testing Services Market for In-Vitro, 2018 - 2030 (USD Billion)
Fig. 26 Global Bioanalytical Testing Services Market for PK, 2018 - 2030 (USD Billion)
Fig. 27 Global Bioanalytical Testing Services Market for PD, 2018 - 2030 (USD Billion)
Fig. 28 Global Bioanalytical Testing Services Market for Bioavailability, 2018 - 2030 (USD Billion)
Fig. 29 Global Bioanalytical Testing Services Market for Bioequivalence, 2018 - 2030 (USD Billion)
Fig. 30 Global Bioanalytical Testing Services Market for Others, 2018 - 2030 (USD Billion)
Fig. 31 Global Bioanalytical Testing Services Market for Sample Preparation, 2018 - 2030 (USD Billion)
Fig. 32 Global Bioanalytical Testing Services Market for Protein Precipitation, 2018 - 2030 (USD Billion)
Fig. 33 Global Bioanalytical Testing Services Market for Liquid-Liquid Extraction, 2018 - 2030 (USD Billion)
Fig. 34 Global Bioanalytical Testing Services Market for Solid Phase Extraction, 2018 - 2030 (USD Billion)
Fig. 35 Global Bioanalytical Testing Services Market for Sample Analysis, 2018 - 2030 (USD Billion)
Fig. 36 Global Bioanalytical Testing Services Market for Hyphenated technique, 2018 - 2030 (USD Billion)
Fig. 37 Global Bioanalytical Testing Services Market for Chromatographic technique, 2018 - 2030 (USD Billion)
Fig. 38 Global Bioanalytical Testing Services Market for Electrophoresis, 2018 - 2030 (USD Billion)
Fig. 39 Global Bioanalytical Testing Services Market for Ligand Binding Assay, 2018 - 2030 (USD Billion)
Fig. 40 Global Bioanalytical Testing Services Market for Mass Spectrometry, 2018 - 2030 (USD Billion)
Fig. 41 Global Bioanalytical Testing Services Market for Nuclear Magnetic Resonance, 2018 - 2030 (USD Billion)
Fig. 42 Global Bioanalytical Testing Services Market for Others, 2018 - 2030 (USD Billion)
Fig. 43 Global Bioanalytical Testing Services Market for Oncology, 2018 - 2030 (USD Billion)
Fig. 44 Global Bioanalytical Testing Services Market for Neurology, 2018 - 2030 (USD Billion)
Fig. 45 Global Bioanalytical Testing Services Market for Infectious Diseases, 2018 - 2030 (USD Billion)
Fig. 46 Global Bioanalytical Testing Services Market for Gastroenterology, 2018 - 2030 (USD Billion)
Fig. 47 Global Bioanalytical Testing Services Market for Cardiology, 2018 - 2030 (USD Billion)
Fig. 48 Global Bioanalytical Testing Services Market for Other Applications, 2018 - 2030 (USD Billion)
Fig. 49 Global Bioanalytical Testing Services Market for Pharma & BioPharma Companies, 2018 - 2030 (USD Billion)
Fig. 50 Global Bioanalytical Testing Services Market for CDMO, 2018 - 2030 (USD Billion)
Fig. 51 Global Bioanalytical Testing Services Market for CRO, 2018 - 2030 (USD Billion)
Fig. 52 Regional Outlook, 2021 & 2030
Fig. 53 North America Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 54 U.S. Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 55 Canada Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 56 Europe Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 57 Germany Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 58 UK Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 59 France Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 60 Italy Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 61 Spain Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 62 Denmark Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 63 Sweden Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 64 Netherlands Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 65 Switzerland Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 66 Norway Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 67 Asia Pacific Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 68 Japan Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 69 China Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 70 India Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 71 Australia Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 72 South Korea Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 73 Thailand Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 74 Indonesia Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 75 Malaysia Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 76 Singapore Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 77 Taiwan Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 78 Latin America Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 79 Brazil Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 80 Mexico Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 81 Argentina Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 82 Colombia Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 83 Middle East and Africa Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 84 South Africa Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 85 Saudi Arabia Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 86 UAE Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 87 Kuwait Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)
Fig. 88 Israel Bioanalytical Testing Services Market 2018 - 2030 (USD Billion)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
    • Small Molecule
    • Large Molecule
      • LC-MS Studies
      • Immunoassays
      • PK
      • ADA
      • Others
    • Others
  • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
    • ADME
      • In-Vivo
      • In-Vitro
    • PK
    • PD
    • Bioavailability
    • Bioequivalence
    • Others
  • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
    • Sample Preparation
      • Protein Precipitation
      • Liquid-Liquid Extraction
      • Solid Phase Extraction
    • Sample Analysis
      • Hyphenated technique
      • Chromatographic technique
      • Electrophoresis
      • Ligand Binding Assay
      • Mass Spectrometry
      • Nuclear Magnetic Resonance
    • Other Workflow Processes
  • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
    • Oncology
    • Neurology
    • Infectious Diseases
    • Gastroenterology
    • Cardiology
    • Other Applications
  • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
    • Pharma & BioPharma Companies
    • CDMO
    • CRO
  • Bioanalytical Testing Services RegionalOutlook (Revenue, USD Billion, 2018- 2030)
    • North America
      • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
        • Small Molecule
        • Large Molecule
          • LC-MS Studies
          • Immunoassays
          • PK
          • ADA
          • Others
        • Others
      • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
        • ADME
          • In-Vivo
          • In-Vitro
        • PK
        • PD
        • Bioavailability
        • Bioequivalence
        • Others
      • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
        • Sample Preparation
          • Protein Precipitation
          • Liquid-Liquid Extraction
          • Solid Phase Extraction
        • Sample Analysis
          • Hyphenated technique
          • Chromatographic technique
          • Electrophoresis
          • Ligand Binding Assay
          • Mass Spectrometry
          • Nuclear Magnetic Resonance
        • Other Workflow Processes
      • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
        • Oncology
        • Neurology
        • Infectious Diseases
        • Gastroenterology
        • Cardiology
        • Other Applications
      • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharma & BioPharma Companies
        • CDMO
        • CRO
      • U.S.
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Canada
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
    • Europe
      • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
        • Small Molecule
        • Large Molecule
          • LC-MS Studies
          • Immunoassays
          • PK
          • ADA
          • Others
        • Others
      • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
        • ADME
          • In-Vivo
          • In-Vitro
        • PK
        • PD
        • Bioavailability
        • Bioequivalence
        • Others
      • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
        • Sample Preparation
          • Protein Precipitation
          • Liquid-Liquid Extraction
          • Solid Phase Extraction
        • Sample Analysis
          • Hyphenated technique
          • Chromatographic technique
          • Electrophoresis
          • Ligand Binding Assay
          • Mass Spectrometry
          • Nuclear Magnetic Resonance
        • Other Workflow Processes
      • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
        • Oncology
        • Neurology
        • Infectious Diseases
        • Gastroenterology
        • Cardiology
        • Other Applications
      • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharma & BioPharma Companies
        • CDMO
        • CRO
      • UK
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Germany
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • France
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Italy
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Spain
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Denmark
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Sweden
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Norway
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Netherlands
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Switzerland
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
    • Asia Pacific
      • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
        • Small Molecule
        • Large Molecule
          • LC-MS Studies
          • Immunoassays
          • PK
          • ADA
          • Others
        • Others
      • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
        • ADME
          • In-Vivo
          • In-Vitro
        • PK
        • PD
        • Bioavailability
        • Bioequivalence
        • Others
      • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
        • Sample Preparation
          • Protein Precipitation
          • Liquid-Liquid Extraction
          • Solid Phase Extraction
        • Sample Analysis
          • Hyphenated technique
          • Chromatographic technique
          • Electrophoresis
          • Ligand Binding Assay
          • Mass Spectrometry
          • Nuclear Magnetic Resonance
        • Other Workflow Processes
      • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
        • Oncology
        • Neurology
        • Infectious Diseases
        • Gastroenterology
        • Cardiology
        • Other Applications
      • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharma & BioPharma Companies
        • CDMO
        • CRO
      • India
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • China
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Japan
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • South Korea
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Australia
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Thailand
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Indonesia
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Malaysia
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Singapore
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Taiwan
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
    • Latin America
      • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
        • Small Molecule
        • Large Molecule
          • LC-MS Studies
          • Immunoassays
          • PK
          • ADA
          • Others
        • Others
      • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
        • ADME
          • In-Vivo
          • In-Vitro
        • PK
        • PD
        • Bioavailability
        • Bioequivalence
        • Others
      • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
        • Sample Preparation
          • Protein Precipitation
          • Liquid-Liquid Extraction
          • Solid Phase Extraction
        • Sample Analysis
          • Hyphenated technique
          • Chromatographic technique
          • Electrophoresis
          • Ligand Binding Assay
          • Mass Spectrometry
          • Nuclear Magnetic Resonance
        • Other Workflow Processes
      • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
        • Oncology
        • Neurology
        • Infectious Diseases
        • Gastroenterology
        • Cardiology
        • Other Applications
      • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharma & BioPharma Companies
        • CDMO
        • CRO
      • Brazil
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Mexico
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Argentina
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Colombia
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
    • Middle East and Africa (MEA)
      • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
        • Small Molecule
        • Large Molecule
          • LC-MS Studies
          • Immunoassays
          • PK
          • ADA
          • Others
        • Others
      • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
        • ADME
          • In-Vivo
          • In-Vitro
        • PK
        • PD
        • Bioavailability
        • Bioequivalence
        • Others
      • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
        • Sample Preparation
          • Protein Precipitation
          • Liquid-Liquid Extraction
          • Solid Phase Extraction
        • Sample Analysis
          • Hyphenated technique
          • Chromatographic technique
          • Electrophoresis
          • Ligand Binding Assay
          • Mass Spectrometry
          • Nuclear Magnetic Resonance
        • Other Workflow Processes
      • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
        • Oncology
        • Neurology
        • Infectious Diseases
        • Gastroenterology
        • Cardiology
        • Other Applications
      • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharma & BioPharma Companies
        • CDMO
        • CRO
      • South Africa
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Saudi Arabia
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • UAE
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Kuwait
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO
      • Israel
        • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
          • Small Molecule
          • Large Molecule
            • LC-MS Studies
            • Immunoassays
            • PK
            • ADA
            • Others
          • Others
        • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
          • ADME
            • In-Vivo
            • In-Vitro
          • PK
          • PD
          • Bioavailability
          • Bioequivalence
          • Others
        • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
          • Sample Preparation
            • Protein Precipitation
            • Liquid-Liquid Extraction
            • Solid Phase Extraction
          • Sample Analysis
            • Hyphenated technique
            • Chromatographic technique
            • Electrophoresis
            • Ligand Binding Assay
            • Mass Spectrometry
            • Nuclear Magnetic Resonance
          • Other Workflow Processes
        • Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
          • Oncology
          • Neurology
          • Infectious Diseases
          • Gastroenterology
          • Cardiology
          • Other Applications
        • Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharma & BioPharma Companies
          • CDMO
          • CRO

Bioanalytical Testing Services Market Dynamics

Driver: Technological advancements and growing R&D investments

Precision-focused advancements in medical diagnostics and therapies are rapidly growing through the integration of Artificial Intelligence (AI). While 2023 marks a notable milestone in the widespread adoption of generative AI across various industries, clinical and bioanalytical laboratories are actively seeking avenues to harness AI methodologies for enhanced operational efficiency, flexibility, & patient-centric outcomes. For instance, digital pathology solutions not only facilitate a more distributed workforce but also present the prospect of employing AI algorithms for image recognition. In the field of genetic medicine and pharmacogenomics applications, AI emerges as a practical means to consolidate vast datasets related to clinical risks, personalized diagnoses, and customized treatment plans into actionable intelligence. Development and usage of advanced bioanalytical technologies for establishing accurate methods to generate regulatory-driven bioanalytical data is also expected to drive overall market growth. Intertek Group is adopting bioanalytical technologies, such as immunochemistry and Quantitative Liquid Chromatography-Mass Spectrometry (LC-MS/MS), for accommodating biology or chemistry of complex analytes and matrix interferences across different arrays of biological samples. The company has specialists in these technologies to help overcome the challenges faced during preclinical or clinical development.

Driver: Regulatory control and increasing awareness regarding bioanalytical testing

Bioanalytical testing is required to comply with a large number of complex standards that help enhance testing, aiding market growth. Companies should consider certain factors before developing a bioanalytical method. A sponsor should understand the analyte of interest, that is, should determine the physicochemical properties of the drug, protein binding, and in vitro as well as in vivo metabolism. In addition, the sponsor should consider prior analytical methods that can be applied. Increasing awareness about product quality, environmental issues, and safety of consumers are driving companies to outsource tests as a means to ensure that their products comply with the aforementioned aspects. This helps them build brand image and protects as well as enhances reputation. The U.S. FDA has conducted workshops for increasing awareness regarding bioanalytical testing and related regulations. The 16th Workshop on Recent Issues in Bioanalysis (16th WRIB) was held in Atlanta, GA, U.S., in September 2022. More than 1,000 professionals from pharmaceutical and biotech companies, Contract Research Organizations (CROs), and various regulatory agencies gathered to actively engage in discussions on the latest topics in bioanalysis. The event comprised three main workshops and seven specialized workshops, spanning a week, to provide comprehensive coverage of major issues in bioanalysis, biomarkers, immunogenicity, gene therapy, cell therapy, & vaccines.

Restraint: Data insecurity

Data insecurity in bioanalytical testing services poses significant risks to the organizations providing these services and the individuals whose data is involved. Bioanalytical testing involves the analysis of biological samples to determine the presence and concentration of specific substances, such as drugs or biomarkers. Unauthorized access to databases containing bioanalytical data can lead to data breaches. This could result from hacking attempts, compromised credentials, or vulnerabilities in the data storage systems. A reciprocal flow of information occurs between the client and an analytical testing firm during the outsourcing of analytical testing processes. Clients often find themselves obligated to divulge confidential information to testing firms, creating the potential for misuse. Without a valid contract outlining information security and privacy measures, discrepancies arise between the parties, eroding mutual trust. This lack of a formal agreement can have detrimental effects, such as tarnishing the consultant's brand image or exposing the client to compromises in confidential data. To prevent such scenarios and mitigate risk, it is crucial to establish a legitimate contract, consensus, or memorandum of understanding between both parties.

What Does This Report Include?

This section will provide insights into the contents included in this bioanalytical testing services market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Bioanalytical testing services market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Bioanalytical testing services market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the bioanalytical testing services market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for bioanalytical testing services market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of bioanalytical testing services market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Bioanalytical Testing Services Market Categorization:

The bioanalytical testing services market was categorized into four segments, namely molecule (Small Molecule, Large Molecule), test (ADME, PK, PD, Bioavailability, Bioequivalence), workflow (Sample Preparation, Sample Analysis), and regional (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Segment Market Methodology:

The bioanalytical testing services market was segmented into molecule, test, workflow, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The bioanalytical testing services market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into thirty-two countries, namely, the U.S.; Canada; the UK.; Germany; France; Italy; Spain; Netherlands; Switzerland; Norway; Denmark; Sweden; India; China; Japan; Australia; South Korea; Indonesia; Malaysia; Singapore; Thailand; Taiwan; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Israel; Kuwait.
Egypt; South Africa; and Nigeria.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Bioanalytical testing services market companies & financials:

The bioanalytical testing services market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Thermo Fisher Scientific Inc (PPD, Inc.) -  Pharmaceutical Product Development, LLC (PPD) provides drug discovery & development and post-approval services as well as compound partnering programs. The company caters to pharmaceuticals, medical device companies, biotechnology institutions, government organizations, and academic institutions. Key therapeutic areas in which the company offers services include cardiology, critical care, dermatology, hematology, oncology, pulmonology, and urology.

  • ICON Plc - ICON plc is a global CRO that provides clinical, consulting, & commercialization services. It specializes in strategic development management and analysis of programs that support clinical development ranging from selection of a compound to phase I to phase IV clinical studies. The company also provides functional outsourcing & laboratory services. Its laboratory services include a range of high-value testing services including vaccine, biomarker, good manufacturing practice, bioanalytical & central laboratory services.

  • Charles River Laboratories International - Charles River Laboratories International, Inc. is a provider of clinical laboratory services and preclinical services for pharmaceutical and biotechnology industries. It operates through three segments: Discovery & Safety Assessment (DSA), Research Models & Services (RMS), and Manufacturing Support. Its DSA segment offerings include bioanalysis, drug metabolism, toxicology, and pharmacokinetics services. It caters its products & services to biotechnology & pharmaceutical companies, medical device companies, hospitals, clinics, and academic institutions.

  • Covance, Inc. - Covance, Inc. is a contract research organization that provides clinical and commercialization services to biopharmaceutical & pharmaceutical industries. The company is owned by LabCorp and provides services in more than 60 countries. It offers a wide range of drug development solutions to pharmaceutical industries and laboratory testing services to chemical industries. It is a key player in discovery, toxicology, & central laboratory services and one of the top companies that provides management services for phase III clinical trials to pharmaceutical industries.

  • IQVIA - IQVIA provides contract research services, technology solutions, and advanced analytics to the global life sciences industry. The company operates through three main business areas: R&D solutions, commercialization solutions, and technology solutions. It serves biotechnology, consumer health, pharmaceuticals, and device & diagnostics companies across North America, Europe, Asia Pacific, & Africa. The company have operations in more than 100 countries.

  • Syneos Health - Syneos Health Inc. provides phase I to phase II clinical development service. The company offers its services to medical devices and biopharmaceutical companies. The company has two functional segments, namely Phase I services and clinical development services. The Phase I service segment includes support for Phase I studies for established compounds, exploratory medicine, and first-in-human studies. The clinical development segment offers global studies, clinical monitoring, patient recruitment, quality assurance reviews, consulting services, investigator recruitment, and study reports to facilitate drug development. The company have presence in more than 110 countries.

  • SGS SA - SGS SA offers inspection, testing, certification, and verification services for various industries. It operates in agriculture & food, chemicals, consumer & retail goods, construction, energy, life sciences, industrial manufacturing, oil & gas, logistics, public sector, mining, and transportation. For life sciences, the company has the following verticals in its services portfolio: clinical research services, laboratory services, biopharmaceutical services, pharmaceutical services, medical devices, health beauty & wellness, quality health safety & environment, and technical staffing services. The company has more than 2,600 offices and laboratories globally.

  • Labcorp (Toxikon) -  LabCorp is involved in the development of drugs and diagnostics. The company serves clients across 100 countries. Its clients include hospitals, physicians, employers, governmental agencies, and other independent clinical laboratories. It has clinical laboratories that are located in the U.S. and other countries, including Canada, the UK, and the UAE.

  • Intertek Group Plc - Intertek Group plc (IGP) is the provider of quality and safety solutions. IGP operates through three reportable segments: Product, Trade, and Resources. Its product segment’s key offerings include inspection & certification services, laboratory testing, quality & performance testing, supplier auditing, vendor compliance, and sustainability analysis. Its trade and resources segment offers technical services, analytical testing services, calibration, and asset integrity services. IGP caters its services to life science, food, pharmaceuticals, and healthcare industries. It has presence in 1,000 locations in over 100 countries.

  • Pace Analytical Services LLC - Pace Analytical Services, Inc. (Pace) is a sampling and analytical testing services company. Pace operates as a subsidiary of LAB Holdings, Inc. It offers chemistry services, such as method development, validation, verification, and method transfer services, including raw material testing, extractable & leachable testing, quality testing, residual solvents testing, environment monitoring, impurities testing, and microbiology laboratory testing. Pace also provides other services such as scientific staffing, instrument sale & services, and consulting. It caters its services through a network of analytical labs and service centers in the U.S. The company has more than 500 certifications.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Bioanalytical Testing Services Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Bioanalytical Testing Services Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
Jump to content
pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.